“…Here we assessed the cardiovascular toxicity of seven known human cardiotoxic drugs and two non-cardiotoxic drugs in zebrafish using six specific phenotypic endpoints: heart rate, heart rhythm, pericardial edema, circulation, hemorrhage and thrombosis. Although these phenotypic endpoints for assessing Widen QRS and QT interval prolongation (Hondeghem and Hoffmann, 2003) Bradycardia, pericardial edema, slower and absent circulation Yes Cyclophosphamide Pericardial effusion, decreased systolic function, heart failure, cardiac tamponade and pericarditis (Katayama et al, 2009;Nakamura et al, 2010) Bradycardia, pericardial edema and slower circulation Yes Nimodipine Bradycardia, hypotension and hypoxemia (Gerloni and Copetti, 2004;Hui and Lau, 2005) Bradycardia, pericardial edema, slower and absent circulation Yes Quinidine QT interval prolongation, bradycardia and hypotension (Falk, 1992;White et al, 2007) Bradycardia, AV block, pericardial edema and slower circulation Yes Terfenadine QT interval prolongation, arrhythmias and torsades de pointes (Eseverri, 2000;Yap and Camm, 2002) Bradycardia, AV block, pericardial edema and slower circulation…”